Novo Nordisk, the Danish pharma company behind Ozempic, made a very dumb decision a few years ago that will massively eat ...

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Drugmakers want more clarity from the Trump administration on the potential pharmaceutical tariffs, which some companies warn ...

Generic Drugs Market Size to Reach USD 769.52 Billion by 2033 | Says Cervicorn ConsultingThe generic drugs market size is reaching an estimated value of USD 830.10 billion by 2034 rising from USD 327.

Introduction Over-the-counter (OTC) use of antibiotics contributes to the burgeoning rise in antimicrobial resistance (AMR). Drawing on qualitative research methods, this article explores the ...

Sandoz: This Swiss-based generic drugmaker ... including Novo Nordisk’s Victoza, Roche’s cancer drugs Rituxan (Truxima) and ...

Pharma companies involved in Vietnam are making more strategic moves to ease potential impacts in the face of US tariff ...

SDZNY, TEVA, and VTRS show resilience with strong biosimilar pipelines and margin strategies amid industry headwinds.

In 2017, scientists at Cincinnati Children's revealed that using antibiotics to protect newborns from dangerous infections often comes with a long-term consequence—a permanently underdeveloped ...

Antibiotics are supposed to wipe out bacteria, yet the drugs can sometimes hand microbes an unexpected advantage. A new study from Rutgers Health shows that ciprofloxacin, a staple treatment for ...

Medicare is negotiating the prices of 15 drugs, including Novo Nordisk's Ozempic. The government has until Nov. 30 to announce the agreed-upon Medicare prices. The lower prices would go into ...

4 These infections can impair quality of life, cognitive function and shunt survival.5 The XABO Antibiotic-Impregnated Catheters offer enhanced infection control, with clinical studies showing a ...